Paul Harker‐Murray

684 total citations
27 papers, 352 citations indexed

About

Paul Harker‐Murray is a scholar working on Pathology and Forensic Medicine, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Paul Harker‐Murray has authored 27 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 12 papers in Oncology and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Paul Harker‐Murray's work include Lymphoma Diagnosis and Treatment (14 papers), CAR-T cell therapy research (6 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). Paul Harker‐Murray is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), CAR-T cell therapy research (6 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). Paul Harker‐Murray collaborates with scholars based in United States, Netherlands and France. Paul Harker‐Murray's co-authors include Kara M. Kelly, John E. Wagner, Peter D. Cole, Richard A. Drachtman, Sarah C. Merkel, Angela Panoskaltsis‐Mortari, James L. Riley, Tatiana N. Golovina, Carl H. June and Bruce R. Blazar and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Paul Harker‐Murray

27 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Harker‐Murray United States	10	130	129	99	74	68	27	352
Valkal Bhatt United States	12	135 1.0×	45 0.3×	69 0.7×	127 1.7×	39 0.6×	46	383
Evren Özdemir Türkiye	10	134 1.0×	124 1.0×	61 0.6×	112 1.5×	25 0.4×	24	448
Núbia Mendonça Brazil	7	146 1.1×	27 0.2×	103 1.0×	53 0.7×	18 0.3×	17	276
Yasutaka Aoyama Japan	11	80 0.6×	77 0.6×	44 0.4×	138 1.9×	11 0.2×	43	294
Caroline L. Furness United Kingdom	12	115 0.9×	42 0.3×	73 0.7×	65 0.9×	13 0.2×	19	317
Erin Coughlin United States	8	86 0.7×	44 0.3×	52 0.5×	131 1.8×	30 0.4×	15	283
Giulio Trapè Italy	10	107 0.8×	30 0.2×	69 0.7×	93 1.3×	13 0.2×	15	294
Parameswaran Anoop India	9	47 0.4×	25 0.2×	50 0.5×	67 0.9×	34 0.5×	48	222
Zeinab Afify United States	9	32 0.2×	30 0.2×	56 0.6×	82 1.1×	35 0.5×	28	338
Kareem Jamani Canada	11	89 0.7×	87 0.7×	30 0.3×	165 2.2×	8 0.1×	37	305

Countries citing papers authored by Paul Harker‐Murray

Since Specialization

Citations

This map shows the geographic impact of Paul Harker‐Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Harker‐Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Harker‐Murray more than expected).

Fields of papers citing papers by Paul Harker‐Murray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Harker‐Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Harker‐Murray. The network helps show where Paul Harker‐Murray may publish in the future.

Co-authorship network of co-authors of Paul Harker‐Murray

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Harker‐Murray. A scholar is included among the top collaborators of Paul Harker‐Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Harker‐Murray. Paul Harker‐Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vega, Raymond B. Mailhot, Paul Harker‐Murray, Christopher J. Forlenza, et al.. (2023). Radiation Therapy Use in Refractory and Relapsed Adolescent and Young Adult Hodgkin Lymphoma: A Report from the Children's Oncology Group. International Journal of Radiation Oncology*Biology*Physics. 117(2). 400–403. 1 indexed citations

Castellino, Sharon M., Lisa Giulino‐Roth, Paul Harker‐Murray, et al.. (2023). Children's Oncology Group's 2023 blueprint for research: Hodgkin lymphoma. Pediatric Blood & Cancer. 70(S6). e30580–e30580. 9 indexed citations

Forlenza, Christopher J., Audrey Mauguen, Ilia N. Buhtoiarov, et al.. (2023). Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma. Blood Advances. 7(13). 3225–3231. 3 indexed citations

Harker‐Murray, Paul, Christine Mauz‐Körholz, Thierry Leblanc, et al.. (2022). Nivolumab, Brentuximab Vedotin, +/- Bendamustine For R/R Hodgkin Lymphoma in Children, Adolescents, and Young Adults. Blood. 141(17). 2075–2084. 17 indexed citations

Leventaki, Vasiliki, et al.. (2021). A complex KMT2A::AFF3 fusion resulting from a three-way chromosomal rearrangement in pediatric B lymphoblastic leukemia. Cancer Genetics. 262-263. 43–46. 1 indexed citations

Forlenza, Christopher J., Audrey Mauguen, Ilia N. Buhtoiarov, et al.. (2021). Brentuximab Vedotin As Consolidation Therapy Following Autologous Stem Cell Transplantation in Children and Adolescents with Relapsed/Refractory Hodgkin Lymphoma: A Multi-Center Retrospective Analysis. Blood. 138(Supplement 1). 2465–2465. 3 indexed citations

Esbenshade, Adam J., Lisa S. Kahalley, Reto M. Baertschiger, et al.. (2019). Mentors’ perspectives on the successes and challenges of mentoring in the COG Young Investigator mentorship program: A report from the Children's Oncology Group. Pediatric Blood & Cancer. 66(10). e27920–e27920. 5 indexed citations

Kelly, Kara M., Stephen Daw, Christine Mauz‐Körholz, et al.. (2019). RESPONSE‐ADAPTED TREATMENT WITH NIVOLUMAB AND BRENTUXIMAB VEDOTIN IN YOUNG PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: CHECKMATE 744 SUBGROUP ANALYSES. Hematological Oncology. 37(S2). 56–57. 3 indexed citations

Harker‐Murray, Paul, Thierry Leblanc, Maurizio Mascarin, et al.. (2018). Response-Adapted Therapy with Nivolumab and Brentuximab Vedotin (BV), Followed By BV and Bendamustine for Suboptimal Response, in Children, Adolescents, and Young Adults with Standard-Risk Relapsed/Refractory Classical Hodgkin Lymphoma. Blood. 132(Supplement 1). 927–927. 11 indexed citations

10.

Esbenshade, Adam J., Christopher R. Pierson, Amanda L. Thompson, et al.. (2017). Long‐term evidence that a pediatric oncology mentorship program for young investigators is feasible and beneficial in the cooperative group setting: A report from the Children's Oncology Group. Pediatric Blood & Cancer. 65(3). 7 indexed citations

11.

Erker, Craig, Paul Harker‐Murray, & Julie‐An Talano. (2016). Usual and Unusual Manifestations of Familial Hemophagocytic Lymphohistiocytosis and Langerhans Cell Histiocytosis. Pediatric Clinics of North America. 64(1). 91–109. 9 indexed citations

12.

Erker, Craig, Paul Harker‐Murray, & Michael J. Burke. (2015). Emerging Immunotherapy in Pediatric Lymphoma. Future Oncology. 12(2). 257–270. 2 indexed citations

13.

Harker‐Murray, Paul, Richard A. Drachtman, David Hodgson, et al.. (2013). Stratification of treatment intensity in relapsed pediatric Hodgkin lymphoma. Pediatric Blood & Cancer. 61(4). 579–586. 30 indexed citations

14.

Fraser, Chris, Patrick A. Brown, Gail Megason, et al.. (2013). Open-label Bendamustine Monotherapy for Pediatric Patients With Relapsed or Refractory Acute Leukemia. Journal of Pediatric Hematology/Oncology. 36(4). e212–e218. 10 indexed citations

15.

Twombley, Katherine, Monica I. Ardura, Paul Harker‐Murray, et al.. (2012). Intraventricular rituximab and systemic chemotherapy for treatment of central nervous system post‐transplant lymphoproliferative disorder after kidney transplantation. Pediatric Transplantation. 16(6). E201–9. 13 indexed citations

16.

Fraser, Christopher, Patrick A. Brown, Gail Megason, et al.. (2011). Open-Label Bendamustine for Pediatric Patients with Relapsed or Refractory Acute Leukemia: Safety and Efficacy Outcomes,. Blood. 118(21). 3602–3602. 1 indexed citations

17.

Harker‐Murray, Paul, Avis J. Thomas, John E. Wagner, et al.. (2008). Allogeneic Hematopoietic Cell Transplantation in Children with Relapsed Acute Lymphoblastic Leukemia Isolated to the Central Nervous System. Biology of Blood and Marrow Transplantation. 14(6). 685–692. 19 indexed citations

18.

Lee‐Sherick, Alisa B., Paul Harker‐Murray, Patricia Ferrieri, Mark R. Schleiss, & Jakub Tolar. (2007). Bacterial meningitis from Rothia mucilaginosa in patients with malignancy or undergoing hematopoietic stem cell transplantation. Pediatric Blood & Cancer. 50(3). 673–676. 26 indexed citations

19.

Crow, Sheri, Vita V. Sullivan, Nigel S. Key, et al.. (2007). Postoperative Coagulopathy in a Pediatric Patient After Exposure to Bovine Topical Thrombin. The Annals of Thoracic Surgery. 83(4). 1547–1549. 18 indexed citations

20.

Sica, Gabriel, et al.. (2002). Adherence of published diabetes mellitus practice guidelines to methodologic standards of guideline development. Endocrinology and Metabolism Clinics of North America. 31(3). 819–828. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact